|
For more than 25 years, Boston Scientific has advanced the practice of less-invasive medicine by providing a portfolio of innovative products, technologies and services across a wide range of medical specialties. Today, Boston Scientific has more than 28,000 employees and 26 manufacturing, distribution and technology centers. As the world's largest medical device company dedicated to less-invasive medicine, Boston Scientific believes that each innovative product is the outcome of strong research and development, intelligent acquisitions, close collaboration with clinicians, outstanding operational and quality processes and a powerful global distribution channel. As a market leader delivering more than 15,000 products to clinicians in over 45 countries, Boston Scientific works every day to build the knowledge, processes and infrastructure it needs to identify opportunities, address new disease areas and support clinicians in advancing the practice of health care around the world. Boston Scientific is pleased to announce that its merger with Guidant is complete. By combining two great companies, we've created a global leader in cardiovascular devices as well as a broad and diverse medical device company with total anticipated revenue of nearly $9 billion in 2006. Boston Scientific has also completed an agreement with Abbott under which Abbott will acquire Guidant's vascular intervention and endovascular businesses, while agreeing to share rights to Guidant's drug-eluting stent program. The new Boston Scientific will provide clinicians with an unparalleled breadth of products, a proven record of research and clinical science, and the promising future of a pipeline that will continue to provide leading technologies tomorrow and beyond. The merger brings together two companies with a proud heritage of health care innovation, a powerful, shared purpose and a workforce that is the most talented, dedicated and innovative in the industry.
|
